Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Hallal
AddedMar 31, 2024
UpdatedMay 31, 2026
David Hallal

David Hallal

Board Member, Scholar Rock Holding

CrunchbaseLinkedIn

David Hallal's Career

Scholar Rock Holding
Scholar Rock Holding

Cambridge, MA, US

Board Member· Board
iTeos Therapeutics
iTeos Therapeutics

Watertown, MA, US

Board Member· Board
Seer
Seer

Redwood City, CA, US

Board Member· Board
Basecamp Bio
Basecamp Bio

Waltham, MA, US

Co-Founder & CEO· C-Suite · Management
ElevateBio
ElevateBio

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Hallal's Career

Scholar Rock Holding
Scholar Rock Holding
Public1142017Cambridge, MA, US
Board Member· Board

Leadership at Scholar Rock Holding

Jay BackstromJay BackstromCEO
Joshua ReedJoshua ReedBoard Member
Srinivas AkkarajuSrinivas AkkarajuBoard Member
Amir NashatAmir NashatBoard Member
Kristina BurowKristina BurowBoard Member
Akshay VaishnawAkshay VaishnawBoard Member

Similar to Scholar Rock Holding

Solid BiosciencesSolid BiosciencesCambridge, MA, USGene Therapy, Therapiesest. 2013Solid BiosciencesCambridge, MA, US · est. 2013

Solid Biosciences Inc., a US-based biotech firm, develops therapies and devices for muscular dystrophy.

Public · $441.3M87
Blueprint MedicinesBlueprint MedicinesCambridge, MA, USCancer Treatmentsest. 2008Blueprint MedicinesCambridge, MA, US · est. 2008

Blueprint Medicines, based in Cambridge, US, develops targeted cancer treatments for genomically defined patients.

Public · $2.4B641
SphynKx TherapeuticsSphynKx TherapeuticsCharlottesville, VA, USBiotechnology, Therapiesest. 2010SphynKx TherapeuticsCharlottesville, VA, US · est. 2010

SphynKx Therapeutics: Innovating biotech solutions for cancer and fibrosis treatment.

Seed · $50k30
iTeos Therapeutics
iTeos Therapeutics
Public$242.7M1252011Watertown, MA, US
Board Member· Board

Leadership at iTeos Therapeutics

Michel DetheuxMichel DetheuxFounder
Ann D. RhoadsAnn D. RhoadsBoard Member
Valerie OdegardValerie OdegardBoard Member
Tim Van HauwermeirenTim Van HauwermeirenBoard Member
Chris BuyseChris BuyseBoard Member
Seer
Seer
Public$169.5M1642017Redwood City, CA, US
Board Member· Board

Leadership at Seer

Bob LangerBob LangerBoard Member
Rachel HaurwitzRachel HaurwitzBoard Member
Philip MaPhilip MaCo-Founder
Terry McguireTerry McguireBoard Member
Omid FarokhzadOmid FarokhzadBoard Member
John BirbeckJohn BirbeckBoard Member
Basecamp Bio
Basecamp Bio
Acquired$14M02021Waltham, MA, US
Co-Founder & CEO· C-Suite · Management

Leadership at Basecamp Bio

Mitchell H. FinerMitchell H. FinerCo-Founder
Vikas SinhaVikas SinhaCo-Founder
ElevateBio
ElevateBio
Series D$1.2B3752017Cambridge, MA, US
Board Member· Board

Leadership at ElevateBio

Karan TakharKaran TakharBoard Member

Similar to ElevateBio

Cellevolve BioCellevolve BioSan Francisco, CA, USCell Therapyest. 2020Cellevolve BioSan Francisco, CA, US · est. 2020

San Francisco-based cell therapy provider, partnering with global innovators to advance and commercialize novel therapeutics.

Seed · $6M9
Cell BioEnginesCell BioEnginesNew York City, NY, USCell Therapiesest. 2022Cell BioEnginesNew York City, NY, US · est. 2022

Cell BioEngines, Inc.: A clinical-stage biotech firm innovating cancer cures with scalable cell therapies.

Pre-Seed · $625k6

David Hallal's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to David Hallal

Lawrence BlattLawrence BlattBoard Member · Aligos TherapeuticsCatherine Chuter HrdyCatherine Chuter HrdyCo-Founder · AlloBezalel ArkushBezalel ArkushFounder · Aveta.LifeBrad MolineBrad MolineCEO · Allo CommunicationsAdam BermanAdam BermanBoard Member · InterVene